The global Complement Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Complement Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Complement Drug.

Report Scope

The Complement Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Complement Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Complement Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Complement Drug Market Report

Report Metric	Details
Report Name	Complement Drug Market
CAGR	5%
Segment by Type	Peptides Antibodies Others
Segment by Application	Blood Disease Kidney Disease Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novartis AG, Alexion Pharmaceuticals, ChemoCentryx, Roche, Apellis, Regeneron, Amgen, Alnylam, UCB, InflaRx, Innate Pharma, Ionis Pharmaceuticals, Avant Immunotherapeutics, Pfizer, Sanofi, Omeros, GenMab, Akari Therapeutics, AbbVie
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Complement Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Complement Drug Market report?

Ans: The main players in the Complement Drug Market are Novartis AG, Alexion Pharmaceuticals, ChemoCentryx, Roche, Apellis, Regeneron, Amgen, Alnylam, UCB, InflaRx, Innate Pharma, Ionis Pharmaceuticals, Avant Immunotherapeutics, Pfizer, Sanofi, Omeros, GenMab, Akari Therapeutics, AbbVie

What are the Application segmentation covered in the Complement Drug Market report?

Ans: The Applications covered in the Complement Drug Market report are Blood Disease, Kidney Disease, Others

What are the Type segmentation covered in the Complement Drug Market report?

Ans: The Types covered in the Complement Drug Market report are Peptides, Antibodies, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Complement Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Peptides

1.2.3 Antibodies

1.2.4 Others

1.3 Market by Application

1.3.1 Global Complement Drug Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Blood Disease

1.3.3 Kidney Disease

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Complement Drug Market Perspective (2019-2030)

2.2 Complement Drug Growth Trends by Region

2.2.1 Global Complement Drug Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Complement Drug Historic Market Size by Region (2019-2024)

2.2.3 Complement Drug Forecasted Market Size by Region (2025-2030)

2.3 Complement Drug Market Dynamics

2.3.1 Complement Drug Industry Trends

2.3.2 Complement Drug Market Drivers

2.3.3 Complement Drug Market Challenges

2.3.4 Complement Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Complement Drug Players by Revenue

3.1.1 Global Top Complement Drug Players by Revenue (2019-2024)

3.1.2 Global Complement Drug Revenue Market Share by Players (2019-2024)

3.2 Global Complement Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Complement Drug Revenue

3.4 Global Complement Drug Market Concentration Ratio

3.4.1 Global Complement Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Complement Drug Revenue in 2023

3.5 Complement Drug Key Players Head office and Area Served

3.6 Key Players Complement Drug Product Solution and Service

3.7 Date of Enter into Complement Drug Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Complement Drug Breakdown Data by Type

4.1 Global Complement Drug Historic Market Size by Type (2019-2024)

4.2 Global Complement Drug Forecasted Market Size by Type (2025-2030)

5 Complement Drug Breakdown Data by Application

5.1 Global Complement Drug Historic Market Size by Application (2019-2024)

5.2 Global Complement Drug Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Complement Drug Market Size (2019-2030)

6.2 North America Complement Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Complement Drug Market Size by Country (2019-2024)

6.4 North America Complement Drug Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Complement Drug Market Size (2019-2030)

7.2 Europe Complement Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Complement Drug Market Size by Country (2019-2024)

7.4 Europe Complement Drug Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Complement Drug Market Size (2019-2030)

8.2 Asia-Pacific Complement Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Complement Drug Market Size by Region (2019-2024)

8.4 Asia-Pacific Complement Drug Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Complement Drug Market Size (2019-2030)

9.2 Latin America Complement Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Complement Drug Market Size by Country (2019-2024)

9.4 Latin America Complement Drug Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Complement Drug Market Size (2019-2030)

10.2 Middle East & Africa Complement Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Complement Drug Market Size by Country (2019-2024)

10.4 Middle East & Africa Complement Drug Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Novartis AG

11.1.1 Novartis AG Company Detail

11.1.2 Novartis AG Business Overview

11.1.3 Novartis AG Complement Drug Introduction

11.1.4 Novartis AG Revenue in Complement Drug Business (2019-2024)

11.1.5 Novartis AG Recent Development

11.2 Alexion Pharmaceuticals

11.2.1 Alexion Pharmaceuticals Company Detail

11.2.2 Alexion Pharmaceuticals Business Overview

11.2.3 Alexion Pharmaceuticals Complement Drug Introduction

11.2.4 Alexion Pharmaceuticals Revenue in Complement Drug Business (2019-2024)

11.2.5 Alexion Pharmaceuticals Recent Development

11.3 ChemoCentryx

11.3.1 ChemoCentryx Company Detail

11.3.2 ChemoCentryx Business Overview

11.3.3 ChemoCentryx Complement Drug Introduction

11.3.4 ChemoCentryx Revenue in Complement Drug Business (2019-2024)

11.3.5 ChemoCentryx Recent Development

11.4 Roche

11.4.1 Roche Company Detail

11.4.2 Roche Business Overview

11.4.3 Roche Complement Drug Introduction

11.4.4 Roche Revenue in Complement Drug Business (2019-2024)

11.4.5 Roche Recent Development

11.5 Apellis

11.5.1 Apellis Company Detail

11.5.2 Apellis Business Overview

11.5.3 Apellis Complement Drug Introduction

11.5.4 Apellis Revenue in Complement Drug Business (2019-2024)

11.5.5 Apellis Recent Development

11.6 Regeneron

11.6.1 Regeneron Company Detail

11.6.2 Regeneron Business Overview

11.6.3 Regeneron Complement Drug Introduction

11.6.4 Regeneron Revenue in Complement Drug Business (2019-2024)

11.6.5 Regeneron Recent Development

11.7 Amgen

11.7.1 Amgen Company Detail

11.7.2 Amgen Business Overview

11.7.3 Amgen Complement Drug Introduction

11.7.4 Amgen Revenue in Complement Drug Business (2019-2024)

11.7.5 Amgen Recent Development

11.8 Alnylam

11.8.1 Alnylam Company Detail

11.8.2 Alnylam Business Overview

11.8.3 Alnylam Complement Drug Introduction

11.8.4 Alnylam Revenue in Complement Drug Business (2019-2024)

11.8.5 Alnylam Recent Development

11.9 UCB

11.9.1 UCB Company Detail

11.9.2 UCB Business Overview

11.9.3 UCB Complement Drug Introduction

11.9.4 UCB Revenue in Complement Drug Business (2019-2024)

11.9.5 UCB Recent Development

11.10 InflaRx

11.10.1 InflaRx Company Detail

11.10.2 InflaRx Business Overview

11.10.3 InflaRx Complement Drug Introduction

11.10.4 InflaRx Revenue in Complement Drug Business (2019-2024)

11.10.5 InflaRx Recent Development

11.11 ChemoCentryx

11.11.1 ChemoCentryx Company Detail

11.11.2 ChemoCentryx Business Overview

11.11.3 ChemoCentryx Complement Drug Introduction

11.11.4 ChemoCentryx Revenue in Complement Drug Business (2019-2024)

11.11.5 ChemoCentryx Recent Development

11.12 Innate Pharma

11.12.1 Innate Pharma Company Detail

11.12.2 Innate Pharma Business Overview

11.12.3 Innate Pharma Complement Drug Introduction

11.12.4 Innate Pharma Revenue in Complement Drug Business (2019-2024)

11.12.5 Innate Pharma Recent Development

11.13 Ionis Pharmaceuticals

11.13.1 Ionis Pharmaceuticals Company Detail

11.13.2 Ionis Pharmaceuticals Business Overview

11.13.3 Ionis Pharmaceuticals Complement Drug Introduction

11.13.4 Ionis Pharmaceuticals Revenue in Complement Drug Business (2019-2024)

11.13.5 Ionis Pharmaceuticals Recent Development

11.14 Avant Immunotherapeutics

11.14.1 Avant Immunotherapeutics Company Detail

11.14.2 Avant Immunotherapeutics Business Overview

11.14.3 Avant Immunotherapeutics Complement Drug Introduction

11.14.4 Avant Immunotherapeutics Revenue in Complement Drug Business (2019-2024)

11.14.5 Avant Immunotherapeutics Recent Development

11.15 Pfizer

11.15.1 Pfizer Company Detail

11.15.2 Pfizer Business Overview

11.15.3 Pfizer Complement Drug Introduction

11.15.4 Pfizer Revenue in Complement Drug Business (2019-2024)

11.15.5 Pfizer Recent Development

11.16 Sanofi

11.16.1 Sanofi Company Detail

11.16.2 Sanofi Business Overview

11.16.3 Sanofi Complement Drug Introduction

11.16.4 Sanofi Revenue in Complement Drug Business (2019-2024)

11.16.5 Sanofi Recent Development

11.17 Omeros

11.17.1 Omeros Company Detail

11.17.2 Omeros Business Overview

11.17.3 Omeros Complement Drug Introduction

11.17.4 Omeros Revenue in Complement Drug Business (2019-2024)

11.17.5 Omeros Recent Development

11.18 GenMab

11.18.1 GenMab Company Detail

11.18.2 GenMab Business Overview

11.18.3 GenMab Complement Drug Introduction

11.18.4 GenMab Revenue in Complement Drug Business (2019-2024)

11.18.5 GenMab Recent Development

11.19 Akari Therapeutics

11.19.1 Akari Therapeutics Company Detail

11.19.2 Akari Therapeutics Business Overview

11.19.3 Akari Therapeutics Complement Drug Introduction

11.19.4 Akari Therapeutics Revenue in Complement Drug Business (2019-2024)

11.19.5 Akari Therapeutics Recent Development

11.20 AbbVie

11.20.1 AbbVie Company Detail

11.20.2 AbbVie Business Overview

11.20.3 AbbVie Complement Drug Introduction

11.20.4 AbbVie Revenue in Complement Drug Business (2019-2024)

11.20.5 AbbVie Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Ionis Pharmaceuticals

Avant Immunotherapeutics

List of Tables

Table 1. Global Complement Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Peptides

Table 3. Key Players of Antibodies

Table 4. Key Players of Others

Table 5. Global Complement Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Complement Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Complement Drug Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Complement Drug Market Share by Region (2019-2024)

Table 9. Global Complement Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Complement Drug Market Share by Region (2025-2030)

Table 11. Complement Drug Market Trends

Table 12. Complement Drug Market Drivers

Table 13. Complement Drug Market Challenges

Table 14. Complement Drug Market Restraints

Table 15. Global Complement Drug Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Complement Drug Market Share by Players (2019-2024)

Table 17. Global Top Complement Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Complement Drug as of 2023)

Table 18. Ranking of Global Top Complement Drug Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Complement Drug Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Complement Drug Product Solution and Service

Table 22. Date of Enter into Complement Drug Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Complement Drug Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Complement Drug Revenue Market Share by Type (2019-2024)

Table 26. Global Complement Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Complement Drug Revenue Market Share by Type (2025-2030)

Table 28. Global Complement Drug Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Complement Drug Revenue Market Share by Application (2019-2024)

Table 30. Global Complement Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Complement Drug Revenue Market Share by Application (2025-2030)

Table 32. North America Complement Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Complement Drug Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Complement Drug Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Complement Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Complement Drug Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Complement Drug Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Complement Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Complement Drug Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Complement Drug Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Complement Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Complement Drug Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Complement Drug Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Complement Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Complement Drug Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Complement Drug Market Size by Country (2025-2030) & (US$ Million)

Table 47. Novartis AG Company Detail

Table 48. Novartis AG Business Overview

Table 49. Novartis AG Complement Drug Product

Table 50. Novartis AG Revenue in Complement Drug Business (2019-2024) & (US$ Million)

Table 51. Novartis AG Recent Development

Table 52. Alexion Pharmaceuticals Company Detail

Table 53. Alexion Pharmaceuticals Business Overview

Table 54. Alexion Pharmaceuticals Complement Drug Product

Table 55. Alexion Pharmaceuticals Revenue in Complement Drug Business (2019-2024) & (US$ Million)

Table 56. Alexion Pharmaceuticals Recent Development

Table 57. ChemoCentryx Company Detail

Table 58. ChemoCentryx Business Overview

Table 59. ChemoCentryx Complement Drug Product

Table 60. ChemoCentryx Revenue in Complement Drug Business (2019-2024) & (US$ Million)

Table 61. ChemoCentryx Recent Development

Table 62. Roche Company Detail

Table 63. Roche Business Overview

Table 64. Roche Complement Drug Product

Table 65. Roche Revenue in Complement Drug Business (2019-2024) & (US$ Million)

Table 66. Roche Recent Development

Table 67. Apellis Company Detail

Table 68. Apellis Business Overview

Table 69. Apellis Complement Drug Product

Table 70. Apellis Revenue in Complement Drug Business (2019-2024) & (US$ Million)

Table 71. Apellis Recent Development

Table 72. Regeneron Company Detail

Table 73. Regeneron Business Overview

Table 74. Regeneron Complement Drug Product

Table 75. Regeneron Revenue in Complement Drug Business (2019-2024) & (US$ Million)

Table 76. Regeneron Recent Development

Table 77. Amgen Company Detail

Table 78. Amgen Business Overview

Table 79. Amgen Complement Drug Product

Table 80. Amgen Revenue in Complement Drug Business (2019-2024) & (US$ Million)

Table 81. Amgen Recent Development

Table 82. Alnylam Company Detail

Table 83. Alnylam Business Overview

Table 84. Alnylam Complement Drug Product

Table 85. Alnylam Revenue in Complement Drug Business (2019-2024) & (US$ Million)

Table 86. Alnylam Recent Development

Table 87. UCB Company Detail

Table 88. UCB Business Overview

Table 89. UCB Complement Drug Product

Table 90. UCB Revenue in Complement Drug Business (2019-2024) & (US$ Million)

Table 91. UCB Recent Development

Table 92. InflaRx Company Detail

Table 93. InflaRx Business Overview

Table 94. InflaRx Complement Drug Product

Table 95. InflaRx Revenue in Complement Drug Business (2019-2024) & (US$ Million)

Table 96. InflaRx Recent Development

Table 97. ChemoCentryx Company Detail

Table 98. ChemoCentryx Business Overview

Table 99. ChemoCentryx Complement Drug Product

Table 100. ChemoCentryx Revenue in Complement Drug Business (2019-2024) & (US$ Million)

Table 101. ChemoCentryx Recent Development

Table 102. Innate Pharma Company Detail

Table 103. Innate Pharma Business Overview

Table 104. Innate Pharma Complement Drug Product

Table 105. Innate Pharma Revenue in Complement Drug Business (2019-2024) & (US$ Million)

Table 106. Innate Pharma Recent Development

Table 107. Ionis Pharmaceuticals Company Detail

Table 108. Ionis Pharmaceuticals Business Overview

Table 109. Ionis Pharmaceuticals Complement Drug Product

Table 110. Ionis Pharmaceuticals Revenue in Complement Drug Business (2019-2024) & (US$ Million)

Table 111. Ionis Pharmaceuticals Recent Development

Table 112. Avant Immunotherapeutics Company Detail

Table 113. Avant Immunotherapeutics Business Overview

Table 114. Avant Immunotherapeutics Complement Drug Product

Table 115. Avant Immunotherapeutics Revenue in Complement Drug Business (2019-2024) & (US$ Million)

Table 116. Avant Immunotherapeutics Recent Development

Table 117. Pfizer Company Detail

Table 118. Pfizer Business Overview

Table 119. Pfizer Complement Drug Product

Table 120. Pfizer Revenue in Complement Drug Business (2019-2024) & (US$ Million)

Table 121. Pfizer Recent Development

Table 122. Sanofi Company Detail

Table 123. Sanofi Business Overview

Table 124. Sanofi Complement Drug Product

Table 125. Sanofi Revenue in Complement Drug Business (2019-2024) & (US$ Million)

Table 126. Sanofi Recent Development

Table 127. Omeros Company Detail

Table 128. Omeros Business Overview

Table 129. Omeros Complement Drug Product

Table 130. Omeros Revenue in Complement Drug Business (2019-2024) & (US$ Million)

Table 131. Omeros Recent Development

Table 132. GenMab Company Detail

Table 133. GenMab Business Overview

Table 134. GenMab Complement Drug Product

Table 135. GenMab Revenue in Complement Drug Business (2019-2024) & (US$ Million)

Table 136. GenMab Recent Development

Table 137. Akari Therapeutics Company Detail

Table 138. Akari Therapeutics Business Overview

Table 139. Akari Therapeutics Complement Drug Product

Table 140. Akari Therapeutics Revenue in Complement Drug Business (2019-2024) & (US$ Million)

Table 141. Akari Therapeutics Recent Development

Table 142. AbbVie Company Detail

Table 143. AbbVie Business Overview

Table 144. AbbVie Complement Drug Product

Table 145. AbbVie Revenue in Complement Drug Business (2019-2024) & (US$ Million)

Table 146. AbbVie Recent Development

Table 147. Research Programs/Design for This Report

Table 148. Key Data Information from Secondary Sources

Table 149. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Complement Drug Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Complement Drug Market Share by Type: 2023 VS 2030

Figure 3. Peptides Features

Figure 4. Antibodies Features

Figure 5. Others Features

Figure 6. Global Complement Drug Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Complement Drug Market Share by Application: 2023 VS 2030

Figure 8. Blood Disease Case Studies

Figure 9. Kidney Disease Case Studies

Figure 10. Others Case Studies

Figure 11. Complement Drug Report Years Considered

Figure 12. Global Complement Drug Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Complement Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Complement Drug Market Share by Region: 2023 VS 2030

Figure 15. Global Complement Drug Market Share by Players in 2023

Figure 16. Global Top Complement Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Complement Drug as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Complement Drug Revenue in 2023

Figure 18. North America Complement Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Complement Drug Market Share by Country (2019-2030)

Figure 20. United States Complement Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Complement Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Complement Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Complement Drug Market Share by Country (2019-2030)

Figure 24. Germany Complement Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Complement Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Complement Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Complement Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Complement Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Complement Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Complement Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Complement Drug Market Share by Region (2019-2030)

Figure 32. China Complement Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Complement Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Complement Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Complement Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Complement Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Complement Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Complement Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Complement Drug Market Share by Country (2019-2030)

Figure 40. Mexico Complement Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Complement Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Complement Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Complement Drug Market Share by Country (2019-2030)

Figure 44. Turkey Complement Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Complement Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Novartis AG Revenue Growth Rate in Complement Drug Business (2019-2024)

Figure 47. Alexion Pharmaceuticals Revenue Growth Rate in Complement Drug Business (2019-2024)

Figure 48. ChemoCentryx Revenue Growth Rate in Complement Drug Business (2019-2024)

Figure 49. Roche Revenue Growth Rate in Complement Drug Business (2019-2024)

Figure 50. Apellis Revenue Growth Rate in Complement Drug Business (2019-2024)

Figure 51. Regeneron Revenue Growth Rate in Complement Drug Business (2019-2024)

Figure 52. Amgen Revenue Growth Rate in Complement Drug Business (2019-2024)

Figure 53. Alnylam Revenue Growth Rate in Complement Drug Business (2019-2024)

Figure 54. UCB Revenue Growth Rate in Complement Drug Business (2019-2024)

Figure 55. InflaRx Revenue Growth Rate in Complement Drug Business (2019-2024)

Figure 56. ChemoCentryx Revenue Growth Rate in Complement Drug Business (2019-2024)

Figure 57. Innate Pharma Revenue Growth Rate in Complement Drug Business (2019-2024)

Figure 58. Ionis Pharmaceuticals Revenue Growth Rate in Complement Drug Business (2019-2024)

Figure 59. Avant Immunotherapeutics Revenue Growth Rate in Complement Drug Business (2019-2024)

Figure 60. Pfizer Revenue Growth Rate in Complement Drug Business (2019-2024)

Figure 61. Sanofi Revenue Growth Rate in Complement Drug Business (2019-2024)

Figure 62. Omeros Revenue Growth Rate in Complement Drug Business (2019-2024)

Figure 63. GenMab Revenue Growth Rate in Complement Drug Business (2019-2024)

Figure 64. Akari Therapeutics Revenue Growth Rate in Complement Drug Business (2019-2024)

Figure 65. AbbVie Revenue Growth Rate in Complement Drug Business (2019-2024)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Chrysalis Oil Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26N13078

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Eucommia Ulmoides Extract Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3L13782

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global MRSA Drugs Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26S13718

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Ferrous Citrate Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-16S12875

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Complement Drug Market Research Report 2024

Published Date: May 2024

Report Code: QYRE-Auto-8O14598

Global Complement Drug Market Research Report 2024

FEATURED COMPANIES

Complement Drug Market Size

Complement Drug Market

Report Scope

Scope of Complement Drug Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Complement Drug Market report?

What are the Application segmentation covered in the Complement Drug Market report?

What are the Type segmentation covered in the Complement Drug Market report?

FEATURED COMPANIES

RELATED REPORTS

$5800

Enterprise User

$5800

Enterprise User

$5800

Enterprise User

$5800

Enterprise User

Surgical Microscopes Market by Application Dentistry ENT Gynecology Urology Neurosurgery Spine Surgery Oncology Ophthalmology and Plastic and Reconstructive Surgeries End user Hospitals and Outpatient facility Global Opportunity Analysis and Industry Forecast 2014 2022

Single User, Electronic (PDF)